Characterization of biotechnology pharmaceutical products: Washington, D. C., USA, December 11 - 13, 1995
Gespeichert in:
| Weitere Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Basel [u.a.]
Karger
1998
|
| Schriftenreihe: | Developments in biological standardization
96 |
| Schlagworte: | |
| Beschreibung: | XI, 207 S. |
| ISBN: | 3805568053 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV024860773 | ||
| 003 | DE-604 | ||
| 005 | 20210702 | ||
| 007 | t | ||
| 008 | 100417s1998 |||| 00||| eng d | ||
| 020 | |a 3805568053 |9 3-8055-6805-3 | ||
| 035 | |a (OCoLC)883491788 | ||
| 035 | |a (DE-599)BVBBV024860773 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-11 | ||
| 084 | |a VX 5508 |0 (DE-625)147800:261 |2 rvk | ||
| 084 | |a WF 9780 |0 (DE-625)148466: |2 rvk | ||
| 245 | 1 | 0 | |a Characterization of biotechnology pharmaceutical products |b Washington, D. C., USA, December 11 - 13, 1995 |c proceedings of a symposium organized and sponsored by The Food and Drug Administration, Center for Biologics Evaluation and Research. Vol. ed. Fred Brown ... |
| 264 | 1 | |a Basel [u.a.] |b Karger |c 1998 | |
| 300 | |a XI, 207 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Developments in biological standardization |v 96 | |
| 650 | 0 | 7 | |a Proteine |0 (DE-588)4076388-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Rekombinantes Protein |0 (DE-588)4277353-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Biotechnologie |0 (DE-588)4069491-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmazeutische Technologie |0 (DE-588)4045699-7 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)1071861417 |a Konferenzschrift |y 1995 |z Washington DC |2 gnd-content | |
| 689 | 0 | 0 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 0 | 1 | |a Proteine |0 (DE-588)4076388-2 |D s |
| 689 | 0 | 2 | |a Biotechnologie |0 (DE-588)4069491-4 |D s |
| 689 | 0 | |8 2\p |5 DE-604 | |
| 689 | 1 | 0 | |a Rekombinantes Protein |0 (DE-588)4277353-2 |D s |
| 689 | 1 | 1 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
| 689 | 1 | 2 | |a Pharmazeutische Technologie |0 (DE-588)4045699-7 |D s |
| 689 | 1 | |8 3\p |5 DE-604 | |
| 700 | 1 | |a Brown, Fred |d 1925-2004 |0 (DE-588)171991923 |4 edt | |
| 710 | 2 | |a Center for Biologics Evaluation and Research (Bethesda, Md.) |e Sonstige |0 (DE-588)2126762-5 |4 oth | |
| 830 | 0 | |a Developments in biological standardization |v 96 |w (DE-604)BV000000884 |9 96 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-019536145 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804141861092196352 |
|---|---|
| any_adam_object | |
| author2 | Brown, Fred 1925-2004 |
| author2_role | edt |
| author2_variant | f b fb |
| author_GND | (DE-588)171991923 |
| author_facet | Brown, Fred 1925-2004 |
| building | Verbundindex |
| bvnumber | BV024860773 |
| classification_rvk | VX 5508 WF 9780 |
| ctrlnum | (OCoLC)883491788 (DE-599)BVBBV024860773 |
| discipline | Chemie / Pharmazie Biologie |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02342nam a2200517 cb4500</leader><controlfield tag="001">BV024860773</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20210702 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">100417s1998 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3805568053</subfield><subfield code="9">3-8055-6805-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)883491788</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV024860773</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-11</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VX 5508</subfield><subfield code="0">(DE-625)147800:261</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WF 9780</subfield><subfield code="0">(DE-625)148466:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Characterization of biotechnology pharmaceutical products</subfield><subfield code="b">Washington, D. C., USA, December 11 - 13, 1995</subfield><subfield code="c">proceedings of a symposium organized and sponsored by The Food and Drug Administration, Center for Biologics Evaluation and Research. Vol. ed. Fred Brown ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel [u.a.]</subfield><subfield code="b">Karger</subfield><subfield code="c">1998</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XI, 207 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Developments in biological standardization</subfield><subfield code="v">96</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Proteine</subfield><subfield code="0">(DE-588)4076388-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Rekombinantes Protein</subfield><subfield code="0">(DE-588)4277353-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biotechnologie</subfield><subfield code="0">(DE-588)4069491-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1995</subfield><subfield code="z">Washington DC</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Proteine</subfield><subfield code="0">(DE-588)4076388-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Biotechnologie</subfield><subfield code="0">(DE-588)4069491-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Rekombinantes Protein</subfield><subfield code="0">(DE-588)4277353-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Pharmazeutische Technologie</subfield><subfield code="0">(DE-588)4045699-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brown, Fred</subfield><subfield code="d">1925-2004</subfield><subfield code="0">(DE-588)171991923</subfield><subfield code="4">edt</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Center for Biologics Evaluation and Research (Bethesda, Md.)</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)2126762-5</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Developments in biological standardization</subfield><subfield code="v">96</subfield><subfield code="w">(DE-604)BV000000884</subfield><subfield code="9">96</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-019536145</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)1071861417 Konferenzschrift 1995 Washington DC gnd-content |
| genre_facet | Konferenzschrift 1995 Washington DC |
| id | DE-604.BV024860773 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T22:22:36Z |
| institution | BVB |
| institution_GND | (DE-588)2126762-5 |
| isbn | 3805568053 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-019536145 |
| oclc_num | 883491788 |
| open_access_boolean | |
| owner | DE-11 |
| owner_facet | DE-11 |
| physical | XI, 207 S. |
| publishDate | 1998 |
| publishDateSearch | 1998 |
| publishDateSort | 1998 |
| publisher | Karger |
| record_format | marc |
| series | Developments in biological standardization |
| series2 | Developments in biological standardization |
| spelling | Characterization of biotechnology pharmaceutical products Washington, D. C., USA, December 11 - 13, 1995 proceedings of a symposium organized and sponsored by The Food and Drug Administration, Center for Biologics Evaluation and Research. Vol. ed. Fred Brown ... Basel [u.a.] Karger 1998 XI, 207 S. txt rdacontent n rdamedia nc rdacarrier Developments in biological standardization 96 Proteine (DE-588)4076388-2 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Rekombinantes Protein (DE-588)4277353-2 gnd rswk-swf Biotechnologie (DE-588)4069491-4 gnd rswk-swf Pharmazeutische Technologie (DE-588)4045699-7 gnd rswk-swf 1\p (DE-588)1071861417 Konferenzschrift 1995 Washington DC gnd-content Arzneimittel (DE-588)4003115-9 s Proteine (DE-588)4076388-2 s Biotechnologie (DE-588)4069491-4 s 2\p DE-604 Rekombinantes Protein (DE-588)4277353-2 s Pharmazeutische Technologie (DE-588)4045699-7 s 3\p DE-604 Brown, Fred 1925-2004 (DE-588)171991923 edt Center for Biologics Evaluation and Research (Bethesda, Md.) Sonstige (DE-588)2126762-5 oth Developments in biological standardization 96 (DE-604)BV000000884 96 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Characterization of biotechnology pharmaceutical products Washington, D. C., USA, December 11 - 13, 1995 Developments in biological standardization Proteine (DE-588)4076388-2 gnd Arzneimittel (DE-588)4003115-9 gnd Rekombinantes Protein (DE-588)4277353-2 gnd Biotechnologie (DE-588)4069491-4 gnd Pharmazeutische Technologie (DE-588)4045699-7 gnd |
| subject_GND | (DE-588)4076388-2 (DE-588)4003115-9 (DE-588)4277353-2 (DE-588)4069491-4 (DE-588)4045699-7 (DE-588)1071861417 |
| title | Characterization of biotechnology pharmaceutical products Washington, D. C., USA, December 11 - 13, 1995 |
| title_auth | Characterization of biotechnology pharmaceutical products Washington, D. C., USA, December 11 - 13, 1995 |
| title_exact_search | Characterization of biotechnology pharmaceutical products Washington, D. C., USA, December 11 - 13, 1995 |
| title_full | Characterization of biotechnology pharmaceutical products Washington, D. C., USA, December 11 - 13, 1995 proceedings of a symposium organized and sponsored by The Food and Drug Administration, Center for Biologics Evaluation and Research. Vol. ed. Fred Brown ... |
| title_fullStr | Characterization of biotechnology pharmaceutical products Washington, D. C., USA, December 11 - 13, 1995 proceedings of a symposium organized and sponsored by The Food and Drug Administration, Center for Biologics Evaluation and Research. Vol. ed. Fred Brown ... |
| title_full_unstemmed | Characterization of biotechnology pharmaceutical products Washington, D. C., USA, December 11 - 13, 1995 proceedings of a symposium organized and sponsored by The Food and Drug Administration, Center for Biologics Evaluation and Research. Vol. ed. Fred Brown ... |
| title_short | Characterization of biotechnology pharmaceutical products |
| title_sort | characterization of biotechnology pharmaceutical products washington d c usa december 11 13 1995 |
| title_sub | Washington, D. C., USA, December 11 - 13, 1995 |
| topic | Proteine (DE-588)4076388-2 gnd Arzneimittel (DE-588)4003115-9 gnd Rekombinantes Protein (DE-588)4277353-2 gnd Biotechnologie (DE-588)4069491-4 gnd Pharmazeutische Technologie (DE-588)4045699-7 gnd |
| topic_facet | Proteine Arzneimittel Rekombinantes Protein Biotechnologie Pharmazeutische Technologie Konferenzschrift 1995 Washington DC |
| volume_link | (DE-604)BV000000884 |
| work_keys_str_mv | AT brownfred characterizationofbiotechnologypharmaceuticalproductswashingtondcusadecember11131995 AT centerforbiologicsevaluationandresearchbethesdamd characterizationofbiotechnologypharmaceuticalproductswashingtondcusadecember11131995 |